↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$666KSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202617:21 | Oct 2, 2026 | NRIXNurix Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1 | $23.19 | −5,786 | 9,110 | -39% | −$134K | ||
| Oct 2, 202617:21 | Oct 2, 2026 | NRIXNurix Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1 | $8.72 | +5,786 | 14,896 | +64% | $50K | ||
| Sep 2, 202619:42 | Sep 2, 2026 | NRIXNurix Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1 | $25.76 | −5,787 | 9,110 | -39% | −$149K | ||
| Sep 2, 202619:42 | Sep 2, 2026 | NRIXNurix Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1 | $8.72 | +5,787 | 14,897 | +64% | $50K | ||
| Aug 3, 202617:51 | Aug 3, 2026 | NRIXNurix Therapeutics, Inc. | Chief Legal Officer | S · Sell10b5-1 | $23.05 | −16,589 | 9,110 | -65% | −$382K | ||
| Aug 3, 202617:51 | Aug 3, 2026 | NRIXNurix Therapeutics, Inc. | Chief Legal Officer | M · Exercise10b5-1 | $8.72 | +5,787 | 25,699 | +29% | $50K |